Search

Author/Creator Jacobi, Oded

2. Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non‐small‐cell lung cancer. Issue 2 (6th August 2020)

Authors:
Icht, Oded; Domachevsky, Liran; Groshar, David; Dudnik, Elizabeth; Rotem, Ofer; Allen, Aaron M.; Peled, Nir; Reinhorn, Daniel; Jacobi, Oded; Shochat, Tzippy; Bernstine, Hanna; Zer, Alona
Journal:
Asia-Pacific journal of clinical oncology
Issue:
Volume 17:Issue 2(2021)
Page Start:
e125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors. (16th March 2021)

Authors:
Icht, Oded; Darzi, Naama; Shimony, Shai; Jacobi, Oded; Reinhorn, Daniel; Landman, Yosef; Mutai, Raz; Averbuch, Itamar; Shochat, Tzippy; Spectre, Galia; Raanani, Pia; Rotem, Ofer; Dudnik, Elizabeth; Peled, Nir; Zer, Alona; Leader, Avi
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 19:Number 5(2021)
Page Start:
1250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗